Physician

Obstetrics & Gynecology

Dr. Charles E. Welander, MD

Charles Welander works in the field of Obstetrics & Gynecology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care Charles Welander has written publications. He has 47 publications published with PubMed. The lastest paper is: 'Advanced ovarian carcinoma presenting with a cerebrovascular accident.'

Publications

Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: cisplatin followed by radiation therapy--a pilot study of the Gynecologic Oncology Group.
Vincristine infusion in refractory gynecologic malignancies.
A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian Cancer.
A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
Postoperative irradiation and chemotherapy in patients with advanced ovarian Cancer.
Preoperative irradiation in stage III carcinoma of the ovary.
Interferon and doxorubicin in renal cell carcinoma.
Intravenous leiomyomatosis with intracardiac extension.
Staging and treatment of endometrial carcinoma.
Laparoscopic radical hysterectomy and laparoscopically assisted vaginal radical hysterectomy with pelvic and paraaortic node dissection.
Advanced ovarian carcinoma presenting with a cerebrovascular accident.
Placenta previa percreta with bladder invasion.
Autologous antibodies eluted from membrane fragments isolated from the effusions of human ovarian epithelial neoplasms. I. Quantitation of antibodies.
Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay.
Pretreatment laparotomy in carcinoma of the cervix.
In vitro growth stimulation of human ovarian Cancer cells by xenogeneic peritoneal macrophages.
In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?
Use of the human tumor stem cell assay to study chemotherapy sensitivity in Cancer of the cervix.
Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
In vitro growth characteristics and chemosensitivities of endometrial Cancer using a soft agar clonogenic assay.
Use of interferon in the treatment of ovarian Cancer as a single agent and in combination with cytotoxic drugs.
Interferons in the treatment of multiple myeloma.
Combined interferon alfa and doxorubicin in the treatment of advanced cervical Cancer.
Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection.
What do CA 125 and other antigens tell us about ovarian Cancer biology?
An in vitro thymidine incorporation assay for human Cancers: technical details revisited.
Four ovarian Cancers diagnosed during laparoscopic management of 1011 women with adnexal masses.
Factors affecting survival in stage I and state II carcinoma of the cervix.
Epithelial ovarian Cancer. Prolonged relapse-free survival following secondary cytoreductive surgery and intraperitoneal 5-fluorouracil.
Antitumor activity of new anthracycline analogues in combination with interferon alfa.
Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugs.
Tenckhoff catheter cytology in patients with ovarian Cancer.
Effects of scheduling and ascites-associated macrophages on combined antiproliferative activity of alpha-2b interferon and gamma-interferon in a clonogenic assay.
A phase II study of the efficacy of recombinant interferon gamma in relapsing ovarian adenocarcinoma.
Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay.
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.
Effect of acoustic shock waves on clonogenic growth and drug sensitivity of human tumor cells in vitro.
CA-125 values predictive of clinical response during second-line chemotherapy for epithelial ovarian Cancer.
In vitro sensitivity of human endometrial Cancer to cytotoxic and biologic agents.
Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinoma.
Interferon in the treatment of ovarian Cancer.
Dosage range study of morphine sulfate controlled-release.
Intralesional interferon alfa-2b for the treatment of genital warts.
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.

Schools

U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
University Nc Hospital
Meml Sloan Kettering Canc C

Procedures Preformed

Gynecologic Cancer Screening

Conditions Treated

Uterine Cancer

Doctors Specialties

Gynecologic Oncology
Obstetrics
Gynecology

Accepted Insurances

Education

Memorial Sloan-Kettering Cancer Center
University of North Carolina Hospitals
University of Chicago Pritzker School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Jennifer Hollings, MD This Doctor is OpenDoctor Recommended.
	Dr. George Chamoun, DO
	Dr. Adrienne L. Maraist, MD This Doctor is OpenDoctor Recommended.
	Dr. Cecelia H. Boardman, MD This Doctor is OpenDoctor Recommended.
	Dr. Leo J. Dunn, MD
	Dr. Tyler C. Ford, MD This Doctor is OpenDoctor Recommended.
	Dr. Johnny Hyde Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. John W. Seeds, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lindsay H. Morrell, MD This Doctor is OpenDoctor Recommended.